David Lawrence
2012
In 2012, David Lawrence earned a total compensation of $1.2M as Chief of Business Operations and Former Chief Financial Officer at Acorda Therapeutics, a 6% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $126,721 |
|---|---|
| Option Awards | $466,601 |
| Salary | $293,683 |
| Stock Awards | $289,850 |
| Other | $7,350 |
| Total | $1,184,205 |
Lawrence received $466.6K in option awards, accounting for 39% of the total pay in 2012.
Lawrence also received $126.7K in non-equity incentive plan, $293.7K in salary, $289.9K in stock awards and $7.4K in other compensation.
Rankings
In 2012, David Lawrence's compensation ranked 5,476th out of 11,487 executives tracked by ExecPay. In other words, Lawrence earned more than 52.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,476 out of 11,487 | 52nd |
Division Manufacturing | 1,928 out of 4,253 | 55th |
Major group Chemicals And Allied Products | 466 out of 1,198 | 61st |
Industry group Drugs | 309 out of 920 | 66th |
Industry Biological Products, Except Diagnostic Substances | 55 out of 160 | 66th |
Source: SEC filing on April 25, 2014.
Lawrence's colleagues
We found four more compensation records of executives who worked with David Lawrence at Acorda Therapeutics in 2012.